Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone versus prednisone + methotrexate in myasthenia gravis
ChiCTR-IPR-15006081Phase 4Recruiting
- Sponsor
- Xuanwu Hospital
- Start
- Jul 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of prednisone and methotrexate in myasthenia gravis (MG) (2 arms), sponsored by Xuanwu Hospital. Primary endpoints: Total prednisone dose per group and Average prednisone consumption per group. Started Jul 2014; status: recruiting.
02
Drugs
prednisonemethotrexate
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on ChiCTR-IPR-15006081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006081.